Last Week Illumina, Inc. (NASDAQ:ILMN) Ratings

Illumina, Inc. (NASDAQ:ILMN) Corporate Logo
Big Money Sentiment decreased to 1.33 in Q3 2018. It has change of 0.20, from 2018Q2’s 1.53. The ratio is negative due to Illumina, Inc. positioning: 35 sold and 207 reduced. 119 funds amassed positions and 202 increased positions. Investors holded 128.56 million in 2018Q2 but now own 126.72 million shares or 1.43% less.
Blackrock reported 11.25M shs. Moreover, Everence Cap Mgmt has 0.24% invested in Illumina, Inc. (NASDAQ:ILMN). 53,933 are owned by Voya Mgmt Ltd Liability Co. Focused Wealth Mngmt owns 358 shs or 0.04% of their US capital. Massachusetts Fin Ma owns 0.01% invested in Illumina, Inc. (NASDAQ:ILMN) for 93,658 shs. Fdx Advsr holds 0.02% or 1,499 shs in its capital. Trustmark State Bank Department holds 0.24% or 9,273 shs in its capital. Walter & Keenan Financial Consulting Co Mi Adv invested 0.73% of its capital in Illumina, Inc. (NASDAQ:ILMN). 4,721 are owned by Rand Wealth Limited. Viking Ltd Partnership has invested 0.78% in Illumina, Inc. (NASDAQ:ILMN). Williams Jones Ltd has invested 0.01% in Illumina, Inc. (NASDAQ:ILMN). Tarbox Family Office holds 0.11% of its capital in Illumina, Inc. (NASDAQ:ILMN) for 863 shs. Balyasny Asset Mngmt Ltd Liability has 72,531 shs for 0.12% of their capital. Moreover, Ithaka Grp Ltd Liability has 3.41% invested in Illumina, Inc. (NASDAQ:ILMN). Amalgamated Financial Bank holds 22,185 shs or 0.2% of its capital.

Illumina, Inc. registered $27.25 million net activity with 0 buys and 31 insider sales since July 23, 2018. OSTADAN OMEAD sold 644 shs worth $207,046. EASTHAM KARIN sold $1.47 million worth of Illumina, Inc. (NASDAQ:ILMN) on Tuesday, November 6. On Monday, October 1 a trade for 1,346 shs valued at $496,876 was made by EPSTEIN ROBERT S. $742,686 worth of stock was sold by deSouza Francis A on Tuesday, September 4. Shares for $352,054 were sold by Stapley Marc on Tuesday, September 4. Dadswell Charles had sold 124 shs worth $36,544.

Illumina, Inc. (NASDAQ:ILMN) Ratings Coverage

In total 8 analysts cover Illumina (NASDAQ:ILMN). “Buy” rating has 7, “Sell” are 0, while 1 are “Hold”. 88% are bullish. 10 are the (NASDAQ:ILMN)’s analyst reports since July 17, 2018 according to StockzIntelligence Inc. On Tuesday, July 31 the firm has “Buy” rating by Citigroup given. The company rating was maintained by PiperJaffray on Tuesday, July 17. The company rating was maintained by Barclays Capital on Wednesday, October 24. On Tuesday, July 31 Barclays Capital maintained the shares of ILMN in report with “Overweight” rating. On Tuesday, August 7 the firm has “Equal-Weight” rating by Morgan Stanley given. In Tuesday, July 31 report Deutsche Bank maintained it with “Buy” rating and $330 target. On Tuesday, July 31 Canaccord Genuity maintained Illumina, Inc. (NASDAQ:ILMN) rating. Canaccord Genuity has “Buy” rating and $340 target. In Friday, August 10 report Argus Research maintained it with “Buy” rating and $372 target. On Monday, January 7 the rating was maintained by Morgan Stanley with “Equal-Weight”. On Thursday, January 3 the stock of Illumina, Inc. (NASDAQ:ILMN) earned “Buy” rating by UBS. Listed here are Illumina, Inc. (NASDAQ:ILMN) PTs and latest ratings.

07/01/2019 Broker: Morgan Stanley Old Rating: Equal-Weight New Rating: Equal-Weight Old Target: $320 New Target: $288 Maintain
03/01/2019 Broker: UBS Old Rating: Neutral New Rating: Buy Old Target: $340 New Target: $370 Upgrade
24/10/2018 Broker: Barclays Capital Old Rating: Overweight New Rating: Overweight Old Target: $350 New Target: $370 Maintain
10/08/2018 Broker: Argus Research Old Rating: Buy New Rating: Buy Old Target: $310 New Target: $372 Maintain
07/08/2018 Broker: Morgan Stanley Old Rating: Underweight New Rating: Equal-Weight Old Target: $210 New Target: $320 Upgrade
31/07/2018 Broker: Barclays Capital Old Rating: Overweight New Rating: Overweight Old Target: $300 New Target: $350 Maintain
31/07/2018 Broker: Deutsche Bank Old Rating: Buy New Rating: Buy Old Target: $280 New Target: $330 Maintain
31/07/2018 Broker: Canaccord Genuity Old Rating: Buy New Rating: Buy Old Target: $330 New Target: $340 Maintain
31/07/2018 Broker: Citigroup Old Rating: Buy New Rating: Buy Old Target: $330 New Target: $345 Maintain
17/07/2018 Broker: PiperJaffray Old Rating: Overweight New Rating: Overweight Old Target: $272 New Target: $329 Maintain

The stock decreased 2.19% or $6.74 during the last trading session, hitting $300.33.Currently Illumina, Inc. is uptrending after 50.49% change in last January 14, 2018. ILMN has also 473,799 shares volume. The stock outperformed the S&P500 by 50.49%.

Illumina, Inc. provides sequencing and array solutions for genetic analysis.The firm is worth $44.15 billion. The companyÂ’s sequencing by synthesis technology provides researchers with various applications and the ability to sequence mammalian genomes.65.01 is the P/E ratio. It also offers arrays for a range of deoxyribonucleic acid and RNA analysis applications, including single nucleotide polymorphism genotyping, copy number variations analysis, gene expression analysis, and methylation analysis, as well as allow for the detection of known genetic markers on a single array.

Illumina, Inc. (NASDAQ:ILMN) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.